Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG in Highly-Sensitized Kidney Transplant Candidates
NCT00000935Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Primary completion
- Jun 2003
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of Gamimune-N in end stage renal disease (ESRD), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
Gamimune-N
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT00000935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000935.